C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/13 (2006.01) C07K 19/00 (2006.01)
Patent
CA 2420829
Construction of a recombinant gene fusion encoding a human IgG1 heavy chain constant region and a single-chain variable fragment antibody of 1A4A1 monoclonal antibody is disclosed. The recombinant antibody of the present invention confers human immune effector functions on marine antibodies. After expression in bacteria as inclusion bodies, the recombinant antibody was purified and refolded in vitro. The recombinant soluble antibody retains high antigen-binding affinity to VEE and possesses some human IgG crystallizable fragment domain functions. On non-reducing gel electrophoresis analysis, disulfide bond formation was found in the hinge region of the recombinant antibody. The present invention shows that the recombinant antibody is in a native, functionally active form and it provides the basis to characterize the recombinant antibody for efficacy in vivo.
Alvi Azhar Z.
Fulton R. Elaine
Hu Weigang
Nagata Leslie P.
Her Majesty The Queen In Right Of Canada As Represented By The Minister Of National Defence
Nelligan O'brien Payne Llp
LandOfFree
Novel fusion protein of human igg1 heavy chain constant... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Novel fusion protein of human igg1 heavy chain constant..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel fusion protein of human igg1 heavy chain constant... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1837798